谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Long-Term Efficacy and Safety of Lebrikizumab is Maintained in Patients with Moderate-to-Severe ​ Atopic Dermatitis: Results Up to 3 Years from ADjoin

Emma Guttman-Yassky,Alan Irvine,Eric Simpson, Melinda Gooderham,Stephan Weidinger,Lynda Spelman,Jonathan Silverberg,Heidi Crane,Hany Elmaraghy, Louise DeLuca-Carter,Maria Lucia Buziqui Piruzeli,Chaoran Hu,Evangeline Pierce,Helena Agell,Diamant Thaçi

SKIN The Journal of Cutaneous Medicine（2025）

引用 0|浏览1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要